MoneyWeek

Best of the financial columnists

NHS has to draw a line somewhere

Max Pemberton

The Spectator

Obesity rates have nearly doubled in the UK since the 1990s and the NHS now spends around £6.5bn a year treating it, says Max Pemberton. Being overweight – which 60% of the UK population now is – costs the NHS twice as much as being a healthy weight. No intervention to reduce the figure has worked, and it is hoped that weight-loss injections known as GLP-1 agonists (Wegovy/Ozempic) could reverse this trend. Rishi Sunak says

You’re reading a preview, subscribe to read more.

More from MoneyWeek

MoneyWeek4 min read
The 2020s Will Soon Begin To Roar
Amid all the despondency about the economic prospects of “the West,” it’s refreshing to find an optimist with a coherent argument. Chris Watling of Longview Economics believes that the West is on the threshold of an economic boom.“It is anathema to t
MoneyWeek8 min read
Until The Pips Squeak
The latest polls show Labour on course for such a thumping majority (with less than 50% of the vote – how rubbish is first-past-the-post?) that it will be able to do what it likes. There is scope for a lot of invasive government. Despite Starmer’s pu
MoneyWeek1 min read
IPO Watch
Luxembourg-based private-equity firm CVC Capital Partners is planning an initial public offering (IPO) of Zabka Polska, valuing Poland’s largest convenience-store chain at between $7.5bn and $8bn, says Bloomberg. Zabaka is expected to list in Warsaw

Related Books & Audiobooks